title: Prophylactic application of levosimendan in cardiac surgical patients with severe left ventricle dysfunction.
abstract: BACKGROUND
  Levosimendan improves myocardial contractility, and increases systemic, pulmonary and coronary vasodilation. The present study investigates the perioperative hemodynamic effects of a prophylactic infusion of levosimendan in high-risk cardiac surgery patients with severe left ventricle dysfunction, and compares short-term clinical outcomes with a historical control group in which dobutamine and milrinone were used.
  
  
  METHODS
  A retrospective, observational study was performed in 10 adult patients with EuroSCOREs greater than six and severe left ventricle dysfunction. In the study group, prophylactic levosimendan infusion was started after the induction of general anesthesia (bolus 24 mug/kg over 10 min; continuous infusion 0.1 mug/kg/min over the next 24 h). The historical control group (12 patients) was treated with dobutamine and milrinone. The hemodynamic measurements were performed at eight predetermined time points. Short-term clinical outcomes recorded in both groups were the length of intensive care unit stay, the need for dialysis, the length of hospital stay, predicted mortality (logistic EuroSCORE) and 30-day mortality.
  
  
  RESULTS
  Hemodynamic measurements performed in the study group revealed an increase in cardiac index 30 min after levosimendan infusion was started. Cardiac performance was sufficient throughout the entire perioperative period. The length of intensive care unit stay was not different between the groups, but the length of hospital stay (10.4+/-5.0 versus 26.6+/-17.6 days; P=0.01) and 30-day mortality (0% versus 41.7%; P=0.04) were significantly lower in levosimendan-treated patients.
  
  
  CONCLUSIONS
  Levosimendan seemed to be an effective choice for preventing left ventricle failure in high-risk cardiac surgical patients with severe left ventricle dysfunction compared with patients receiving dobutamine and milrinone.
authors.affiliation: Department of Anesthesiology and Intensive Care Medicine;
authors.forename: Ales
authors.initials: A
authors.lastname: Brezina
authors.forename: Hynek
authors.initials: H
authors.lastname: Riha
authors.forename: Jan
authors.initials: J
authors.lastname: Pirk
references.citation: Anesth Analg. 2007 Apr;104(4):766-73
references.pmid: 17377079
references.citation: Eur J Anaesthesiol. 2008 Mar;25(3):224-9
references.pmid: 17892614
references.citation: J Clin Pharmacol. 2002 Jan;42(1):43-51
references.pmid: 11808823
references.citation: Ann Thorac Surg. 2006 Apr;81(4):1536-46
references.pmid: 16564321
references.citation: J Am Coll Cardiol. 2004 Jun 16;43(12):2177-82
references.pmid: 15193677
references.citation: Eur J Pharmacol. 2001 Oct 12;428(3):311-4
references.pmid: 11689188
references.citation: J Cardiothorac Vasc Anesth. 2008 Oct;22(5):693-8
references.pmid: 18922425
references.citation: Rev Esp Cardiol. 2006 Apr;59(4):338-45
references.pmid: 16709386
references.citation: J Cardiothorac Vasc Anesth. 2008 Oct;22(5):699-705
references.pmid: 18922426
references.citation: Med Sci Monit. 2004 Aug;10(8):MT89-93
references.pmid: 15278007
references.citation: Br J Anaesth. 2006 Jun;96(6):694-700
references.pmid: 16595616
references.citation: Anesthesiology. 2006 Mar;104(3):556-69
references.pmid: 16508404
references.citation: Drugs. 2001;61(5):613-27; discussion 628-9
references.pmid: 11368286